[{"NetIncomeLossConverted_3_Q3_USD":2967165000.0,"NetIncomeLossConverted_1_Q3_USD":1314824000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29746000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29721000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":290594000.0,"EarningsPerShareDiluted_1_Q3_USD":43.64,"EarningsPerShareDiluted_3_Q3_USD":98.46,"StockholdersEquity_0_Q3_USD":8825145000.0,"RevenuesConverted_1_Q3_USD":647263000.0,"RevenuesConverted_3_Q3_USD":1755787000.0,"Assets_0_Q3_USD":12020931000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30128000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30137000.0,"EarningsPerShareBasic_1_Q3_USD":44.24,"EarningsPerShareBasic_3_Q3_USD":99.75,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20201030"}]